SharonAI Holdings, Inc Class A Common Stock (SHAZ) | Q4 2025 | 186,391.94% |
Pulsenmore Ltd Ordinary Shares (PLSM) | Q4 2025 | 703.15% |
Charming Medical Limited Class A Ordinary Shares (MCTA) | Q4 2025 | 539.54% |
Damora Therapeutics (DMRA) | Q4 2025 | 532.14% |
Aimei Health Technology Co, Ltd Ordinary Share (AFJK) | Q4 2025 | 464.71% |
Praxis Precision Medicines (PRAX) | Q4 2025 | 458.85% |
MaxsMaking Inc Class A Ordinary Shares (MAMK) | Q4 2025 | 439.42% |
Magnitude International Ltd Ordinary Shares (MAGH) | Q4 2025 | 386.33% |
WeShop Holdings Limited Class A Ordinary Shares (WSHP) | Q4 2025 | 374.53% |
NovaBay Pharmaceuticals (NBY) | Q4 2025 | 354.84% |
Alto Neuroscience (ANRO) | Q4 2025 | 345% |
Omeros (OMER) | Q4 2025 | 318.9% |
MMTEC (MTC) | Q4 2025 | 300.47% |
Capricor Therapeutics (CAPR) | Q4 2025 | 300.28% |
Hycroft Mining (HYMC) | Q4 2025 | 277.9% |
AXT (AXTI) | Q4 2025 | 264.14% |
Society Pass (SOPA) | Q4 2025 | 227.59% |
T1 Energy (TE) | Q4 2025 | 207.83% |
Sidus Space (SIDU) | Q4 2025 | 201.92% |
PACS (PACS) | Q4 2025 | 183.32% |
Rani Therapeutics (RANI) | Q4 2025 | 181.25% |
Micromobility (MCOM) | Q4 2025 | 175% |
Alto Ingredients (ALTO) | Q4 2025 | 174.29% |
Lipocine (LPCN) | Q4 2025 | 174.06% |
Roadzen (RDZN) | Q4 2025 | 171.09% |
